业内首个从实务角度对于生物药CRO，制造企业面对的海关风险深度培训之课程。
Do you have those troubles & risks?
* Pre-classification issue
Base on the H.S. code, some biopharmaceutical products are involved CCC, and the 3C application need a lot of documention and a very long time which cannot meet the time requirements of CRO’s clinical trial.
* Timeliness and expiration issue
A repetitious levy based on the value of the biopharmaceutical products happens when exchange repeat between oversea and domestic customers many times.
* Confidential Issue
Customers or suppliers, unable or unwilling, for the protection of trade secrets reason, to provide ingredient, function, use, composition and other details of the biopharmaceutical products.
* The heel of achilles
An authorization must be obtained before Import/Export your biopharmaceutical products like reagent, protein and accompany intermediate. A license must to be gained before every shipment. Some Import/Export authorization is unable to obtain due to CRO company's business scope limited.
Top 5 reasons to attend
You can learn the latest trends in CIQ policy for CRO industry!
It’s a great opportunity to network with layer, consultant & more!
To know how to speed up the customs process, save time and cost!
Familiar with the legal clause, prevent the Pre-classification risks!
Familiar with the tax issue about tariff and VAT!
仅余8席，更多培训内容，费用等信息请即刻联系培训负责人：Terry KIM
- 会议时间： 2013-04-09至 2013-04-10
- 会议地点： 上海
- 电话：021-50589600
- 传真：
- 联系人：Terry
- Email： t.kim@opplandcorp.com
- 联系地址：2102-2103, Suncome Liauw's Plaza, 738 Shangcheng Road, Shanghai, 200120 CHINA
- 会议网址：
声明：
1.丁香会议频道仅负责发布会议信息，如需参会、获取邀请函或会议日程，请与主办单位联系
2.部分会议信息来自互联网，如您发现信息有误，请联系meeting@dxy.cn纠错
3.如您发现信息不全，可点击Google搜索更多
4.更多服务信息请点击这里
